(Q46036396)

18 December 2017

title

Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. (English)

1 reference

18 December 2017

author name string

Bansal-Pakala P

series ordinal

1 reference

18 December 2017

Jember AG

series ordinal

1 reference

18 December 2017

Croft M

series ordinal

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

18 December 2017

published in

Nature Medicine

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

907-912

1 reference

18 December 2017

The mechanism of immunological paralysis.

cites work

1 reference

7 January 2021

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

1 reference

7 January 2021

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

1 reference

7 January 2021

Acquisition of immunologic self-tolerance

1 reference

7 January 2021

1 reference

7 January 2021

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

7 January 2021

B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance

1 reference

7 January 2021

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

7 January 2021

Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells

1 reference

7 January 2021

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

1 reference

7 January 2021

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion

1 reference

7 January 2021

Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor

1 reference

7 January 2021

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection

1 reference

7 January 2021

Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions

1 reference

7 January 2021

Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand

1 reference

7 January 2021

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

1 reference

7 January 2021

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

1 reference

7 January 2021

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

1 reference

7 January 2021

OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand

1 reference

7 January 2021

A cell culture model for T lymphocyte clonal anergy

1 reference

7 January 2021

Immunological activity of covalently linked T-cell epitopes

1 reference

7 January 2021

In vivo induction of tolerance in murine CD4+ cell subsets

1 reference

7 January 2021

T cell priming versus T cell tolerance induced by synthetic peptides

1 reference

7 January 2021

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

1 reference

7 January 2021

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

7 January 2021

Role of antigen-presenting cells in mediating tolerance and autoimmunity

1 reference

7 January 2021

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism

1 reference

7 January 2021

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

1 reference

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

7 January 2021

Models of T cell anergy: is there a common molecular mechanism?

1 reference

7 January 2021

Blocked Ras activation in anergic CD4+ T cells

1 reference

7 January 2021

Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4+ T Cells

1 reference

7 January 2021

Transactivation by AP-1 is a molecular target of T cell clonal anergy

1 reference

7 January 2021

In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors

1 reference

7 January 2021

p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes

1 reference

7 January 2021

4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB

1 reference

7 January 2021

Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation

1 reference

7 January 2021

Identifiers

DOI

10.1038/90942

1 reference

18 December 2017

1 reference

18 December 2017